Diagnamed Holdings Corp.
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commerc… Read more
Diagnamed Holdings Corp. (DGNMF) - Total Liabilities
Latest total liabilities as of September 2025: $666.47K USD
Based on the latest financial reports, Diagnamed Holdings Corp. (DGNMF) has total liabilities worth $666.47K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Diagnamed Holdings Corp. - Total Liabilities Trend (2021–2025)
This chart illustrates how Diagnamed Holdings Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Diagnamed Holdings Corp. Competitors by Total Liabilities
The table below lists competitors of Diagnamed Holdings Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sirona Biochem Corp
PINK:SRBCF
|
USA | $4.27 Million |
|
Shuttle Pharmaceuticals Inc
NASDAQ:SHPH
|
USA | $2.15 Million |
|
Kula Gold Ltd
AU:KGD
|
Australia | AU$620.24K |
|
Damodar Industries Limited
NSE:DAMODARIND
|
India | ₹2.04 Billion |
|
ARCUS DEVELOPMENT
MU:AJR
|
Germany | €194.18K |
|
Exemplar REITail Ltd
JSE:EXP
|
South Africa | ZAC4.71 Billion |
|
Guardforce AI Co. Limited Warrant
NASDAQ:GFAIW
|
USA | $13.28 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Diagnamed Holdings Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Diagnamed Holdings Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Diagnamed Holdings Corp. (2021–2025)
The table below shows the annual total liabilities of Diagnamed Holdings Corp. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $666.47K | +42.74% |
| 2024-09-30 | $466.91K | +9.51% |
| 2023-09-30 | $426.38K | +15.39% |
| 2022-09-30 | $369.51K | +145.94% |
| 2021-09-30 | $150.24K | -- |